|Title:||Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation|
|Abstract:||A class of pyrazolyl benzenesulfonamide compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula II: ##STR1## or a pharmaceutically-acceptable salt thereof.|
|Inventor(s):||Talley; John J. (St. Louis, MO), Penning; Thomas D. (Elmhurst, IL), Collins; Paul W. (Deerfield, IL), Rogier, Jr.; Donald J. (St. Louis, MO), Malecha; James W. (Libertyville, IL), Miyashiro; Julie M. (Chicago, IL), Bertenshaw; Stephen R. (Brentwood, MO), Khanna; Ish K. (Vernon Hills, IL), Graneto; Matthew J. (St. Louis, MO), Rogers; Roland S. (Richmond Heights, MO), Carter; Jeffery S. (Chesterfield, MO), Docter; Stephen H. (Mt. Prospect, IL), Yu; Stella S. (Morton Grove, IL)|
|Assignee:||G.D. Searle & Co. (Skokie, IL)|
Patent Claim Types:|
see list of patent claims
Field: Not categorized
Back Citations: 10th percentile
Forward Citations: 7th percentile
|PCT Filed||November 14, 1994||PCT Application Number:||PCT/US94/12720|
|PCT Publication Date:||June 08, 1995||PCT Publication Number:||WO95/15316|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.